Aenixit Tablet is manufactured by Albion Laboratories Limited. Aenixit Tablet contains 0.5 mg+10 mg Flupentixol + Melitracen. It is Combined anxiolytics & anti-depressant drugs class drug.
Flupenthixol primarily acts as a neuroleptic drug. The antipsychotic effect of Flupenthixol is achieved by mixed blockade of dopamine D1 and D2 receptors. In the mesolimbic dopamine system of the brain, this accounts for the antipsychotic action of this drug. Flupenthixol has other effects on CNS. In the chemoreceptor trigger zone, the dopamine blockade accounts for the antiemetic effect of the drug.
Melitracen is a tricyclic antidepressant. It blocks the neuronal re-uptake of both serotonin and nor-epinephrine in the central nervous system, there by minimizing the symptoms of depression.
Different types of anxiety, depression & apathy. These include- psychogenic depression, depressive neuroses, masked depression, psychosomatic affections accompanied by anxiety and apathy, menopausal depressions, dysphoria and depression in alcoholics and drug-addicts.
|Generic:||Flupentixol + Melitracen|
|Weight:||0.5 mg+10 mg|
|Therapeutic Class:||Combined anxiolytics & anti-depressant drugs|
|Manufacturer:||Albion Laboratories Limited|
|Last Updated:||November 19, 2020 at 6:15 pm|
Table Of contents
Aenixit contains Flupentixol + Melitracen 0.5 mg+10 mg. Aenixit Dosage:
Adults: In general 2 tablets per day, morning and at midday. For the severe cases, the amount of the morning dose can be increased to 2 tablets.
Elderly patients: One tablet in the morning.
Maintenance dose: 1 tablet in the morning. In cases of insomnia or severe restlessness additional treatment with a sedative in acute phase is recommended.
In the recommended doses side effects are rare. These could be transient restlessness and insomnia.
If previously the patient has been treated with tranquilizers with sedative effect these should be withdrawn gradually.
Flupentixol-melitracen may enhance the response to alcohol, barbiturates and other CNS depressants. Simultaneous administration of MAO-inhibitors may cause hypertensive crises. Neuroleptics and thymoleptics reduce the antihypertensive effect of guanethidine and similar acting compounds and thymoleptics enhance the effects of adrenaline and noradrenaline.
Pregnancy Lactation use
Flupentixol and Melitracen should preferably not be given during pregnancy and lactation.
The immediate recovery phase after myocardial infarction. Defects in bundle-branch conduction. Untreated narrow angle glaucoma. Acute alcohol, barbiturate and opiate intoxication. Flupentixol and Melitracen should not be given to patients who have received a MAO inhibitor within two weeks. Not recommended for excitable patient since its activating effect may lead to exaggeration of these characteristics.
Children: This tablet is not for paediatric use.
Interaction with other Medicine
Should be stored at a cool and dry place, protect from light and moisture.